AlgaeCytes

United Kingdom
Kent, Sandwich, United Kingdom
+44 (0) 1304 897 626 ★

Company profile

AlgaeCytes company profile

AlgaeCytes Limited has developed a proven innovative approach to the production of Omega 3 fatty acids, which are polyunsaturated fatty acids used in numerous bodily functions, such as controlling blood clotting and building cell membranes in the brain. Associated with many health benefits, including protection against heart disease and possibly stroke, new studies are identifying potential benefits for a wide range of conditions including cancer, inflammatory bowel disease and other auto-immune diseases such as lupus and rheumatoid arthritis.

Business identity

Contact email
[email protected]
Phone number
+44 (0) 1304 897 626
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
2010-01-01

Headquarters

Headquarters
Kent, Sandwich, United Kingdom
Postal code
CT13 9ND
Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding rounds
3
Total equity funding
$5.7M
Last funding
Grant / $12.6M / 2022-01-14
Last equity funding
Series Unknown / $5.7M
Investors
2
Lead investors
2
Articles
6

Founders and investors

Lead investors

Deepbridge CapitalFederal Ministry for Economic Affairs and Energy (BMWi)

Investors

Deepbridge CapitalFederal Ministry for Economic Affairs and Energy (BMWi)

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.